/Companies

Liquidia Corporation

NASDAQ: LQDA

Morrisville, US · Founded 2020 · Delaware corporation · 292 employees on LinkedIn · 3 known investors

Find your way into Liquidia Corporation

Liquidia develops and commercializes inhaled and injectable therapies for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. The company sells YUTREPIA, an inhaled dry-powder formulation of treprostinil approved by the FDA in May 2025, and shares profits from a generic treprostinil injection marketed by Sandoz, while advancing a pipeline of investigational formulations targeting additional respiratory and vascular diseases.

Founders & leadership

DDDamian deGoa
Damian deGoaDirector, Board Of Directors
MKMichael Kaseta
Michael KasetaChief Financial Officer and Chief Operating Officer

Board

PBPaul B. Manning
Paul B. ManningBoard directorChairman and CEO at PBM Capital
SBStephen Bloch
Stephen BlochChairman Of The BoardGeneral Partner at Canaan Partners
JH
Joanna HorobinBoard director
RS
Raman SinghBoard director
RARoger A. Jeffs
Roger A. JeffsChief Executive OfficerCo-Founder & Vice Chairman at Kriya Therapeutics
AK
Arthur KirschBoard director
DJ
David JohnsonBoard director
KR
Katherine Rielly-GauvinBoard director

Investors · 3

Reported raises · per SEC filings

Form D private placements

$21.7M disclosed across 1 round · 2021

▶$21.7MraisedApr 2021 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul B. ManningDirector
  • Joanna HorobinDirector
  • Raman SinghDirector
  • Stephen BlochDirector
  • Roger A. JeffsDirector
  • Damian deGoaExecutive Officer, Director
  • Arthur KirschDirector
  • Michael KasetaExecutive Officer
  • David JohnsonDirector
  • Katherine Rielly-GauvinDirector
Offering amount
$21.7M
Amount sold
$21.7M
First sale
Apr 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Liquidia Corporation went on to found or lead other companies.

Competitors · 2

by search overlap

Companies competing with Liquidia Corporation for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Liquidia Corporation do?
Liquidia develops and commercializes inhaled and injectable therapies for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. The company sells YUTREPIA, an inhaled dry-powder formulation of treprostinil approved by the FDA in May 2025, and shares profits from a generic treprostinil injection marketed by Sandoz, while advancing a pipeline of investigational formulations targeting additional respiratory and vascular diseases.
Who are Liquidia Corporation's investors?
Liquidia Corporation's investors include Canaan Partners, New Enterprise Associates (NEA), PBM Capital.
How much funding has Liquidia Corporation raised?
Liquidia Corporation has disclosed $21.7M raised across 1 round.
Where is Liquidia Corporation headquartered?
Liquidia Corporation is headquartered in Morrisville, US.